← Open Payments lookup

IMRAN TRIMZI: Open Payments

NPI 1467502773 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$199 in 8 payments from 6 companies in 2025. Trend: 2023 $162 · 2024 $449 · 2025 $199

Food & beverage: $199
CompanyPaymentsAmount
ABBVIE INC.2$65
Neurocrine BioSciences, Inc.2$54
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$27
Axsome Therapeutics, Inc.1$20
Alkermes, Inc.1$18
Otsuka America Pharmaceutical, Inc.1$14

Products named: VRAYLAR, INGREZZA, CAPLYTA, Auvelity, LYBALVI, REXULTI.

Industry payments across DE — which companies pay providers there.